Archive by date | March 22nd, 2012

Will work for cash

Will work for cash

Three years ago, at the 3rd Plant-Based Vaccines & Antibodies meeting in Verona , I proposed what I thought was a novel idea to move the field of “pharming” forward.  With Andres Wigdorovitz from Buenos Aires in Argentina, I suggested that companies in the USA and Europe could advance their recombinant plant-produced biologicals product development very significantly by investing in research groups in countries like Argentina and South Africa, where the science was essentially on par with northern countries, but personnel and facilities cost far less.  Moreover, the regulatory and ethical frameworks are often as sophisticated as those of developed countries, and according to the most recent annual report of the International Service for the Acquisition of Agribiotech Applications (ISAAA), in fact developing countries are among the leading proponents of the use of GM plants.  Read more